These findings have accelerated basic and clinical studies on the stimulation of BAT formation and activity as a potential therapeutic target against obesity and insulin resistance [9]; however, an alternative strategy independent of UCP1 thermogenesis is needed for BAT-negative individuals. Here, UCP1 is linked to obesity due to melanocortin 4 receptor deficiency.